Ratings by Accountability Research (Kadambari Daptardar)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/23/2026 | Thermo Fisher Scientific | TMO | Upgrade | Buy (Hold) |
510.93 (528.51) |
3.44% | Details | |
| 3/6/2025 | salesforce.com | CRM | Upgrade | Buy (Hold) |
291.97 (171.22) |
-41.36% | Details | |
| 12/5/2024 | salesforce.com | CRM | Downgrade | Hold (Buy) |
367.87 (171.22) |
-53.46% | Details | |
| 6/3/2024 | salesforce.com | CRM | Upgrade | Buy (Hold) |
234.44 (171.22) |
-26.97% | Details | |
| 3/11/2024 | salesforce.com | CRM | Downgrade | Hold (Buy) |
305.28 (171.22) |
-43.91% | Details | |
| 2/15/2024 | Thermo Fisher Scientific | TMO | Downgrade | Hold (Buy) |
548.27 (510.93) |
-6.81% | Details |
